Pulmuone Corporate

KOSE:A017810 Stock Report

Market Cap: ₩406.2b

Pulmuone Balance Sheet Health

Financial Health criteria checks 1/6

Pulmuone has a total shareholder equity of ₩528.6B and total debt of ₩824.1B, which brings its debt-to-equity ratio to 155.9%. Its total assets and total liabilities are ₩2,226.0B and ₩1,697.4B respectively. Pulmuone's EBIT is ₩76.8B making its interest coverage ratio 1.3. It has cash and short-term investments of ₩229.2B.

Key information

155.9%

Debt to equity ratio

₩824.10b

Debt

Interest coverage ratio1.3x
Cash₩229.17b
Equity₩528.60b
Total liabilities₩1.70t
Total assets₩2.23t

Recent financial health updates

Pulmuone (KRX:017810) Use Of Debt Could Be Considered Risky

Jul 26
Pulmuone (KRX:017810) Use Of Debt Could Be Considered Risky

Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Feb 18
Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Nov 20
These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Recent updates

At ₩11,410, Is Pulmuone Corporate (KRX:017810) Worth Looking At Closely?

Nov 15
At ₩11,410, Is Pulmuone Corporate (KRX:017810) Worth Looking At Closely?

Pulmuone (KRX:017810) Use Of Debt Could Be Considered Risky

Jul 26
Pulmuone (KRX:017810) Use Of Debt Could Be Considered Risky

Pulmuone's (KRX:017810) Returns Have Hit A Wall

Jun 12
Pulmuone's (KRX:017810) Returns Have Hit A Wall

Pulmuone Corporate (KRX:017810) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

May 24
Pulmuone Corporate (KRX:017810) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

Market Participants Recognise Pulmuone Corporate's (KRX:017810) Revenues Pushing Shares 31% Higher

May 24
Market Participants Recognise Pulmuone Corporate's (KRX:017810) Revenues Pushing Shares 31% Higher

We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Mar 27
We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Is Now An Opportune Moment To Examine Pulmuone Co., Ltd. (KRX:017810)?

Apr 13
Is Now An Opportune Moment To Examine Pulmuone Co., Ltd. (KRX:017810)?

There Are Reasons To Feel Uneasy About Pulmuone's (KRX:017810) Returns On Capital

Mar 26
There Are Reasons To Feel Uneasy About Pulmuone's (KRX:017810) Returns On Capital

Pulmuone Co., Ltd. (KRX:017810) Is Yielding 0.6% - But Is It A Buy?

Mar 08
Pulmuone Co., Ltd. (KRX:017810) Is Yielding 0.6% - But Is It A Buy?

Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Feb 18
Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Does Pulmuone's (KRX:017810) Share Price Gain of 57% Match Its Business Performance?

Jan 31
Does Pulmuone's (KRX:017810) Share Price Gain of 57% Match Its Business Performance?

Based On Its ROE, Is Pulmuone Co., Ltd. (KRX:017810) A High Quality Stock?

Jan 13
Based On Its ROE, Is Pulmuone Co., Ltd. (KRX:017810) A High Quality Stock?

When Should You Buy Pulmuone Co., Ltd. (KRX:017810)?

Dec 26
When Should You Buy Pulmuone Co., Ltd. (KRX:017810)?

Key Things To Watch Out For If You Are After Pulmuone Co., Ltd.'s (KRX:017810) 0.6% Dividend

Dec 08
Key Things To Watch Out For If You Are After Pulmuone Co., Ltd.'s (KRX:017810) 0.6% Dividend

These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Nov 20
These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Financial Position Analysis

Short Term Liabilities: A017810's short term assets (₩729.7B) do not cover its short term liabilities (₩1,089.0B).

Long Term Liabilities: A017810's short term assets (₩729.7B) exceed its long term liabilities (₩608.4B).

Debt to Equity History and Analysis

Debt Level: A017810's net debt to equity ratio (112.5%) is considered high.

Reducing Debt: A017810's debt to equity ratio has increased from 90.6% to 155.9% over the past 5 years.

Debt Coverage: A017810's debt is not well covered by operating cash flow (18.4%).

Interest Coverage: A017810's interest payments on its debt are not well covered by EBIT (1.3x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 14:53
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pulmuone Corporate is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yu-jung HanDaishin Securities Co. Ltd.
So Min OhEugene Investment & Securities Co Ltd.
Ju Lee SohnKB Investment & Securities Co., Ltd.